These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2822371)

  • 1. [Gyrase inhibitors modify metabolising processes in the liver].
    Staib AH; Harder S; Papenburg A; Stille W
    Dtsch Med Wochenschr; 1987 Oct; 112(44):1720-1. PubMed ID: 2822371
    [No Abstract]   [Full Text] [Related]  

  • 2. Gyrase-inhibitors impair caffeine elimination in man.
    Staib AH; Harder S; Mieke S; Beer C; Stille W; Shah P
    Methods Find Exp Clin Pharmacol; 1987 Mar; 9(3):193-8. PubMed ID: 3037212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistance against new gyrase inhibitors--1985/86].
    Shah PM; Just G; Weigand G; Stille W
    Dtsch Med Wochenschr; 1987 May; 112(22):903-4. PubMed ID: 3034545
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H
    Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Grimm H
    Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin, ofloxacin, enoxacin and ciprofloxacin, against Vibrio cholerae O-1].
    Matsushita S; Yamada S; Kudoh Y; Ohashi M
    Kansenshogaku Zasshi; 1987 Mar; 61(3):292-6. PubMed ID: 3112282
    [No Abstract]   [Full Text] [Related]  

  • 7. 4-quinolones inhibit biotransformation of caffeine.
    Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
    Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
    Marty N; Clave D; Cancet B; Henry-Ferry S; Didier J
    Pathol Biol (Paris); 1988 May; 36(5):460-4. PubMed ID: 3136426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluoroquinolones].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gyrase inhibitors can delay caffeine elimination].
    Staib AH; Harder S; Mieke S; Beer C; Stille W; Shah PM; Frech K
    Dtsch Med Wochenschr; 1986 Sep; 111(39):1500. PubMed ID: 3463500
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between quinolones and caffeine.
    Staib AH; Stille W; Dietlein G; Shah PM; Harder S; Mieke S; Beer C
    Drugs; 1987; 34 Suppl 1():170-4. PubMed ID: 3481318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G; Segura J; de la Torre R; Carbó M
    Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
    Appleman ME; Hadfield TL; Gaines JK; Winn RE
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):131-3. PubMed ID: 2892608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N; Goh KS; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I; Verbist L; Vandepitte J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.